The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: Response to treatment with bevacizumab.
J. M. Fleagle
No relevant relationships to disclose
R. K. Bobba
No relevant relationships to disclose
R. F. Khozouz
No relevant relationships to disclose
P. Garg
No relevant relationships to disclose
C. G. Kardinal
No relevant relationships to disclose
C. Freter
No relevant relationships to disclose